Special Feature: Dr. Tuncay Delibasi at NeuroResearch Day Stem Cell-Derived Islets and the Future of Diabetes Therapy

At Islet Nexus, we’re proud to highlight not only the work happening within our lab, but also the voices shaping the broader scientific community. This week, we spotlight a recent presentation by our principal investigator, Dr. Tuncay Delibasi, at NeuroResearch Day—a vibrant event bringing together leading researchers from across disciplines to discuss cutting-edge advances in stem cell-derived organoids, including neural, cardiac, and pancreatic models.

In his talk, Dr. Delibaşi shared the latest progress from our lab on generating insulin-producing islets from stem cells. His presentation outlined the current strategies in differentiating mesenchymal stem cells into functional islet cells, with a vision toward treating insulin-dependent diabetes through islet transplantation.

The discussion also shed light on the real-world challenges in translating this research into clinical therapies—such as ensuring graft survival, achieving immune protection, and improving vascular integration of transplanted islets. These hurdles remain central to making stem cell–based therapies a reliable and lasting solution for patients.

NeuroResearch Day reminded us how collaborative and interdisciplinary this field truly is. We were inspired by groundbreaking talks on brain organoids, cardiac tissue engineering, and beyond—each one a step closer to unlocking the regenerative potential of stem cells.

We’re honored to have Dr. Delibaşi representing our lab and contributing to these important conversations at the forefront of regenerative medicine.

Tags: #NeuroResearchDay #StemCellTherapies #DiabetesResearch #Organoids #IsletTransplantation